NATICK, Mass., April 26 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the company's Board of Directors elected Kristina M. Johnson, Ph.D. and Nancy-Ann DeParle as Directors. Dr. Johnson and Ms. DeParle were members of the board of directors of Guidant Corporation, which was acquired by the company last week. With the election of Dr. Johnson and Ms. DeParle, the Boston Scientific Board increases from 12 to 14 members.

Kristina M. Johnson, 48, is the Dean of the Pratt School of Engineering at Duke University, a position she has held since 1999. Previously, she served as a professor in the Electrical and Computer Engineering Department, University of Colorado and director of the National Science Foundation Engineering Research Center for Optoelectronics Computing Systems at the University of Colorado, Boulder. Dr. Johnson is a co-founder of the Colorado Advanced Technology Institute Center of Excellence in Optoelectronics and serves as a director of Minerals Technologies, Inc. and AES Corporation. Dr. Johnson was a Fulbright Faculty Scholar in the Department of Electrical Engineering at the University of Edinburgh, Scotland, and a NATO Post-Doctoral Fellow at Trinity College, Dublin, Ireland. Dr. Johnson received B.S., M.S. and Ph.D. degrees in electrical engineering from Stanford University.

Nancy-Ann DeParle, 49, is a Senior Advisor for JP Morgan Partners, LLC, and an Adjunct Professor at The Wharton School of the University of Pennsylvania. Previously, she served as the Administrator of the Health Care Financing Administration (HCFA) (now the Centers for Medicare and Medicaid Services). Prior to her role at HCFA, Ms. DeParle was the Associate Director for Health and Personnel at the White House Office of Management and Budget and served as commissioner of the Tennessee Department of Human Services. Ms. DeParle is a director of Cerner Corporation, DaVita Inc. and Triad Hospitals, Inc. She is also a trustee of the Robert Wood Johnson Foundation and serves on the Medicare Payment Advisory Commission. Ms. DeParle received a B.A. degree from the University of Tennessee, a J.D. from Harvard Law School, and B.A. and M.A. degrees in Politics and Economics from Balliol College of Oxford University, where she was a Rhodes Scholar.

"We are very pleased to welcome Kristina and Nancy-Ann to Boston Scientific," said Pete Nicholas, Chairman of the Boston Scientific Board of Directors. "Their leadership, intellect and years of experience will be extremely valuable to our company, especially as we begin our combination with Guidant. They are people of exceptional capability and achievement, and we are honored to have them join Boston Scientific at such a momentous time in our history."

The new Board members were elected as of April 24, the first business day after the closing of the Guidant acquisition. They have each been nominated for re-election at the company's annual meeting of stockholders on May 9, 2006.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional

medical specialties. For more information, please visit: http://www.bostonscientific.com/.

This press release contains forward-looking statements. Boston Scientific wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with new product development and commercialization, clinical trials, intellectual property, regulatory approvals, competitive offerings, integration of acquired companies, Boston Scientific's overall business strategy, and other factors described in Boston Scientific's filings with the Securities and Exchange Commission.

  CONTACT: Milan Kofol
           508-650-8569
           Investor Relations
           Boston Scientific Corporation

           Paul Donovan
           508-650-8541
           Media Relations
           Boston Scientific Corporation

SOURCE: Boston Scientific Corporation

CONTACT: Milan Kofol, Investor Relations, +1-508-650-8569, or Paul
Donovan, Media Relations, +1-508-650-8541, both of Boston Scientific
Corporation

Web site: http://www.bostonscientific.com/